Weird to say it about a nearly $150B company, but this could've been something of a game changer. Certainly a resounding success would've taken this upward 20% in the short term with huge cash streams to come. I get that it wasn't included in company forecasts, but it doesn't alter the fact that this does harm the medium term growth of the business given a lot of success is naturally priced into CSL.
Ann: Top-line Results from the Phase 3 AEGIS-II Trial, page-22
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$282.85 |
Change
1.510(0.54%) |
Mkt cap ! $136.4B | |||
| Open | High | Low | Value | Volume |
| $283.00 | $284.64 | $281.78 | $98.57M | 347.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 232 | $282.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $282.86 | 9 | 2 |
View Market Depth
| Last trade - 15.02pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$282.63 |
Change
1.510 ( 0.58 %) |
||||
| Open | High | Low | Volume | ||
| $283.00 | $284.55 | $281.86 | 13718 | ||
| Last updated 15.22pm 04/06/2024 ? | |||||
| CSL (ASX) Chart |